Market Overview

Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Estimates

Share:
Related UTHR
H.C. Wainwright Downgrades United Therapeutics To Neutral
7 Largest Price Target Changes For Wednesday
Related ENDP
Benzinga's Top Upgrades
Goldman Initiates Specialty Pharma At Neutral, Highlights 'A Confluence Of Concerns'
My Most Bearish Valuation Of Lannett (Seeking Alpha)

Below are the top drug manufacturers-other stocks on the NASDAQ in terms of earnings estimate for the next year.

United Therapeutics (NASDAQ: UTHR) is likely to earn $6.96 per share in the next year ending December, 2014. United Therapeutics' trailing-twelve-month ROE is 24.83%.

Endo Health Solutions (NASDAQ: ENDP) may earn $3.83 per share in the next year ending December, 2014. Endo Health's trailing-twelve-month revenue is $3.03 billion.

The Medicines Company (NASDAQ: MDCO) is projected to earn $1.15 per share for the next year ending December, 2014. Medicines Company's trailing-twelve-month operating margin is 16.42%.

Cubist Pharmaceuticals (NASDAQ: CBST) is expected to earn $1.14 per share over the next year ending December, 2014. Cubist's trailing-twelve-month ROA is 2.54%.

Posted-In: Drug Manufacturers-Other Industry EPS Estimates NASDAQTrading Ideas

 

Related Articles (CBST + ENDP)

View Comments and Join the Discussion!